Business Standard

Pharmaceuticals firm Laurus Labs Q3 net drops 43% to Rs 155 crore

Pharmaceuticals firm Laurus Labs said its consolidated net profit declined by 43 per cent to Rs 154.97 crore for the third quarter ended December 31, 2021.

Laurus Labs

Laurus Labs

Press Trust of India New Delhi
Pharmaceuticals firm Laurus Labs on Thursday said its consolidated net profit declined by 43 per cent to Rs 154.97 crore for the third quarter ended December 31, 2021.
The company had posted a consolidated net profit of Rs 272.85 crore in the October-December period of previous fiscal.
Revenue from operations fell to Rs 1,028.76 crore in the third quarter as compared to Rs 1,288.42 crore in the same period of 2020-21, Laurus Labs said in a regulatory filing.
"Our Q3 results were impacted by lower sales of ARV APIs and formulations due to stocking at channel partners and we expect improvement from Q4," Laurus Labs founder and CEO Satyanarayana Chava said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Topics : Companies

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Jan 27 2022 | 9:48 PM IST

Explore News